Table 5 Demographic and clinical parameters of patients who receive curative resection at the same period of 2019 and 2020
From: The impact of COVID-19 pandemic on colorectal cancer patients: a single-center retrospective study
Parameters | 2019 (N = 828) | 2020 (N = 710) | χ2/t value | p value |
|---|---|---|---|---|
Gender | Â | Â | 0.123 | 0.726 |
 Male | 518 (62.6) | 438 (61.7) |  |  |
 Female | 310 (37.4) | 272 (38.3) |  |  |
Age(years)a | Â | Â | 0.706 | 0.401 |
  < 70 | 673 (81.3) | 565 (79.6) |  |  |
  ≥ 70 | 155 (18.7) | 145 (20.4) |  |  |
Area of origin | Â | Â | 0.107 | 0.743 |
 Local | 212 (25.6) | 187 (26.3) |  |  |
 Migrant | 616 (74.4) | 523 (73.7) |  |  |
CRC location | Â | Â | 2.336 | 0.311 |
 Right colon | 181 (21.9) | 166 (23.4) |  |  |
 Left colon | 276 (33.3) | 211 (29.7) |  |  |
 Rectum | 371 (44.8) | 333 (46.9) |  |  |
Neoadjuvant chemotherapy | Â | Â | 2.596 | 0.124 |
 Received | 110 (13.3) | 115 (16.2) |  |  |
Neoadjuvant radiotherapy for rectal cancer | Â | Â | 4.451 | 0.039 |
 Received | 65 (17.5) | 79 (23.9) |  |  |
Operative methods |  |  | 15.333 |  < 0.001 |
 Laparoscopic | 327 (39.5) | 351 (49.4) |  |  |
 Laparotomy | 501 (60.5) | 359 (50.6) |  |  |
Transfusion | Â | Â | 0.002 | 0.963 |
 Received | 52 (6.3) | 45 (6.3) |  |  |
Enterostomy | Â | Â | 5.163 | 0.023 |
 Received | 109 (13.2) | 123 (17.3) |  |  |
Major complication | Â | Â | 1.121 | 0.290 |
 Occurrence | 42 (5.1) | 28 (3.9) |  |  |
Preoperative waiting (d.)a | 3.8 ± 2.8 | 4.8 ± 3.0 | − 6.817 |  < 0.001 |
Postoperative stay (d.)a | 7.2 ± 2.8 | 8.4 ± 3.1 | − 7.945 |  < 0.001 |
Hospital stay (d.)a | 11.0 ± 4.0 | 13.2 ± 4.5 | − 10.298 |  < 0.001 |